Literature DB >> 2338119

Oral salbutamol decreases serum digoxin concentration.

M Edner1, T Jogestrand.   

Abstract

The effect of a therapeutic dose of oral salbutamol on serum and skeletal muscle digoxin concentrations has been studied in volunteers digitalised with digoxin. On one occasion a biopsy was taken from the quadriceps after 2 h of supine rest and then 3-4 mg salbutamol was given orally. Blood samples were taken before and after that dose and another muscle biopsy specimen was taken from the same thigh 180 min after the medication. On another occasion control blood sampling, ECG and blood pressure recordings were made but without muscle biopsies or salbutamol administration. Compared to the control measurements, salbutamol decreased the serum digoxin concentration (0.30 nmol.l-1). It also reduced the serum potassium concentration (0.58 mmol.l-1). The digoxin concentration in skeletal muscle did not change significantly after the intake of salbutamol. Thus, even a therapeutic oral dose of salbutamol reduces the serum digoxin concentration in man.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338119     DOI: 10.1007/bf00265984

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Beta-blockade and binding of digoxin to skeletal muscle.

Authors:  T Joreteg; T Jogestrand
Journal:  Clin Physiol       Date:  1986-04

2.  Effect of salbutamol on digoxin concentration in serum and skeletal muscle.

Authors:  M Edner; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

4.  Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity.

Authors:  T Joreteg; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Serum digoxin determination in outpatients--need for standardization.

Authors:  T Jogestrand; R Nordlander
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

6.  Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle.

Authors:  T Clausen; J A Flatman
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

7.  Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.

Authors:  T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

  7 in total
  3 in total

1.  Salbutamol effects on systemic potassium dynamics during and following intense continuous and intermittent exercise.

Authors:  Muath M Altarawneh; Aaron Petersen; Robert Smith; David M Rouffet; Francois Billaut; Ben D Perry; Victoria L Wyckelsma; Antony Tobin; Michael J McKenna
Journal:  Eur J Appl Physiol       Date:  2016-10-22       Impact factor: 3.078

2.  Effect of salbutamol on digoxin pharmacokinetics.

Authors:  M Edner; T Jogestrand; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.